EXCLUSIVE: Pfizer recalls bacteria-fighting antibiotic Zithromax from UAE market
'Pfizer is recalling Zithromax 250mg capsules due to a manufacturing-related matter, which does not impact product quality or safety,' a Pfizer spokesperson told Arabian Business.
'Pfizer has determined the root cause and is working to implement appropriate corrective and preventive actions.'
The company emphasised patient concerns are being addressed. 'We fully realise the importance of this medicine for patients and are working as quickly as possible to resolve the matter. Patients currently taking the product should consult with their healthcare provider about alternative treatment options.'
The recall, which reportedly occurred approximately 2-3 weeks ago, has left pharmacies across the UAE without stock of the widely prescribed medication, according to multiple pharmacy sources contacted by Arabian Business.
Zithromax, which contains azithromycin, is commonly prescribed to treat various bacterial infections, including respiratory infections, skin infections, ear infections, and sexually transmitted infections such as chlamydia. The medication is also used to prevent infections caused by Mycobacterium Avium-intracellulare Complex (MAC) in certain patients.
Pharmacies confirm recall
Arabian Business contacted several pharmacies across Dubai to confirm the recall. Staff at multiple locations verified that the medication had been pulled from shelves.
'The company took back all stock, it has not come back into the market yet. They didn't disclose the reason why. It was recalled 2-3 weeks ago,' said a pharmacist at MedX Pharmacy's Al Barsha branch.
A representative at another MedX branch in Dubai provided further insight. 'It was recalled almost a month ago. I guess it was a bad batch. It hasn't caused much issues in the market as there are alternative brands of the same type of antibiotic available.'
Similarly, a staff member at Aster Pharmacy's Pinnacle Tower branch confirmed, 'They recalled them a long time ago. We haven't been receiving anything. There are different brands of antibiotics people are using.'
The medication works by stopping the growth of bacteria that cause infections and is not effective against viral infections such as the common cold or flu.
Health authorities typically issue recalls of pharmaceutical products when issues related to safety, efficacy, or quality control are identified. These can range from manufacturing inconsistencies to contamination or labelling errors.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Post
06-08-2025
- Arabian Post
Pfizer Romania recognized as a Best Place to Work for 2025
BUCHAREST, ROMANIA – Media OutReach Newswire – 6 August 2025 – Pfizer Romania has been officially certified as one of the, a recognition that highlights its commitment to fostering a workplace culture grounded in integrity, inclusion, and employee empowerment. The Best Places to Work program is a leading international certification that honors organizations providing exceptional employee experiences. The evaluation combines anonymous employee feedback with a comprehensive HR assessment, measuring areas such as leadership, culture, well-being, growth opportunities, and people practices. A Workplace Defined by Purpose, Trust, and Inclusion ADVERTISEMENT Pfizer Romania's certification was driven by impressive scores across key dimensions of workplace culture. According to the internal employee survey: Leadership & Trust 94% of employees say leaders respect labor laws 89% believe leaders act with integrity and ethics 86% agree leadership communicates a clear and inspiring vision Culture of Inclusion 94% say differences (gender, ethnicity, age) do not affect how people are treated 90% feel their ideas and opinions are respected 91% say integrity is a shared value across teams Managerial Support 93% say their manager upholds ethical standards 90% feel supported in health and well-being 88% receive meaningful feedback to grow Engagement & Purpose 86% overall employee satisfaction 86% align with Pfizer's commitment to social responsibility 83% rate HR practices as people-focused Strong HR Practices Back the Recognition In addition to the strong employee feedback, Pfizer Romania achieved impressive results in the HR assessment, which benchmarks the company's practices against recognized global standards. The results reflect how closely Pfizer Romania's approach aligns with best-in-class HR practices across multiple areas: 94% alignment with best practices in people-focused HR policies 90% alignment in leadership support and strategic direction 89% alignment in employee engagement initiatives 88% alignment in teamwork and cross-functional collaboration 81% alignment with best practices in benefits programs 73% alignment in compensation structures and fairness 93% alignment in community involvement and corporate social responsibility, reinforcing Pfizer's strong commitment to societal impact Leadership Reflections 'Being recognized as a Best Place to Work reinforces our belief that a successful business starts with a strong culture,' said Mirela Iordan, General Manager of Pfizer Romania. 'Our values — Courage, Equity, Excellence, and Joy — are not just words; they guide how we lead, collaborate, and deliver on our mission.' Iulia-Rodica Mateescu, Senior Manager, People Experience, added: 'We're honored by this recognition. It reflects our ongoing efforts to create an environment where every team member feels heard, valued, and supported to grow.' Hashtag: #BestPlacesToWork The issuer is solely responsible for the content of this announcement. About Pfizer Romania Pfizer Romania, a subsidiary of Pfizer Inc., has been serving Romanian communities for over 30 years, delivering innovative medicines and vaccines across multiple therapeutic areas. Guided by the global mission 'Breakthroughs that change patients' lives,' the company collaborates closely with healthcare providers and institutions to expand access to quality healthcare and advance public health outcomes. About the Best Places to Work Program Best Places to Work is a global HR certification program that identifies leading employers around the world. The certification process includes a rigorous evaluation of workplace culture through employee surveys and an audit of HR practices across eight key areas, including leadership, well-being, inclusion, and career development. Learn more at: LinkedIn: Best Places to Work
Zawya
06-08-2025
- Zawya
Pfizer Romania recognized as a Best Place to Work for 2025
BUCHAREST, ROMANIA - Media OutReach Newswire - 6 August 2025 - Pfizer Romania has been officially certified as one of the Best Places to Work in Romania for 2025, a recognition that highlights its commitment to fostering a workplace culture grounded in integrity, inclusion, and employee empowerment. The Best Places to Work program is a leading international certification that honors organizations providing exceptional employee experiences. The evaluation combines anonymous employee feedback with a comprehensive HR assessment, measuring areas such as leadership, culture, well-being, growth opportunities, and people practices. A Workplace Defined by Purpose, Trust, and Inclusion Pfizer Romania's certification was driven by impressive scores across key dimensions of workplace culture. According to the internal employee survey: Leadership & Trust 94% of employees say leaders respect labor laws 89% believe leaders act with integrity and ethics 86% agree leadership communicates a clear and inspiring vision Culture of Inclusion 94% say differences (gender, ethnicity, age) do not affect how people are treated 90% feel their ideas and opinions are respected 91% say integrity is a shared value across teams Managerial Support 93% say their manager upholds ethical standards 90% feel supported in health and well-being 88% receive meaningful feedback to grow Engagement & Purpose 86% overall employee satisfaction 86% align with Pfizer's commitment to social responsibility 83% rate HR practices as people-focused Strong HR Practices Back the Recognition In addition to the strong employee feedback, Pfizer Romania achieved impressive results in the HR assessment, which benchmarks the company's practices against recognized global standards. The results reflect how closely Pfizer Romania's approach aligns with best-in-class HR practices across multiple areas: 94% alignment with best practices in people-focused HR policies 90% alignment in leadership support and strategic direction 89% alignment in employee engagement initiatives 88% alignment in teamwork and cross-functional collaboration 81% alignment with best practices in benefits programs 73% alignment in compensation structures and fairness 93% alignment in community involvement and corporate social responsibility, reinforcing Pfizer's strong commitment to societal impact Leadership Reflections "Being recognized as a Best Place to Work reinforces our belief that a successful business starts with a strong culture," said Mirela Iordan, General Manager of Pfizer Romania. "Our values — Courage, Equity, Excellence, and Joy — are not just words; they guide how we lead, collaborate, and deliver on our mission." Iulia-Rodica Mateescu, Senior Manager, People Experience, added: "We're honored by this recognition. It reflects our ongoing efforts to create an environment where every team member feels heard, valued, and supported to grow." Hashtag: #BestPlacesToWork The issuer is solely responsible for the content of this announcement. About Pfizer Romania Pfizer Romania, a subsidiary of Pfizer Inc., has been serving Romanian communities for over 30 years, delivering innovative medicines and vaccines across multiple therapeutic areas. Guided by the global mission "Breakthroughs that change patients' lives," the company collaborates closely with healthcare providers and institutions to expand access to quality healthcare and advance public health outcomes. About the Best Places to Work Program Best Places to Work is a global HR certification program that identifies leading employers around the world. The certification process includes a rigorous evaluation of workplace culture through employee surveys and an audit of HR practices across eight key areas, including leadership, well-being, inclusion, and career development. Learn more at: LinkedIn: Best Places to Work
Gulf Today
29-06-2025
- Gulf Today
CDC says COVID vaccine protects pregnant women
Michael Hiltzik, Tribune News Service Here's how one of the well-laid plans of Health and Human Services Secretary Robert F. Kennedy Jr. went blooey. Earlier this month, Kennedy dismantled the all-important Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and remade it into the spearhead for his anti-vaccination campaigns. The rejiggered committee met for the first time Wednesday. Unfortunately for Kennedy's goals, the very first presentation it heard from CDC scientists involved the safety of the COVID-19 vaccine, particularly for pregnant women, infants and children. CDC studies found "no increased risk" that the Moderna and Pfizer mRNA vaccines caused adverse effects during pregnancy, Sarah Meyer, director of the CDC's Immunization Safety Office, said at the meeting, citing data from 28 analyses of 68,000 pregnant women. The data showed no increases in miscarriages, stillbirths, preterm births, major birth defects, neonatal ICU admissions, infant deaths, abnormal uterine bleeding or other pregnancy-related conditions. In fact, the CDC found that "maternal vaccination is the best proection against COVID-19 for pregnant women and infants less than six months of age," CDC immunologist Adam MacNeil told the panel. The COVID vaccines aren't approved for infants younger than six months, so maternal immunization is their only protection. That's important because Kennedy, on May 17, removed the vaccines from the recommended list for pregnant women and children. "It's common sense and it's good science" to remove the recommendation, Kennedy said in a 58-second video posted on X. "We're now one step closer to realising President Trump's promise to make America healthy again," Kennedy crowed, flanked by Marty Makary, the newly appointed commissioner of the Food and Drug Administration, and Jay Bhattacharya, the newly appointed director of the National Institutes of Health. Neither body plays a role in issuing vaccine recommendations for the government. That's the job of the CDC, which has been operating without a director, and which didn't have a representative on the video. Pediatric and obstetric organisations decried the decision, which ran counter to the findings of extensive research. "Clear benefits of maternal immunisation versus COVID in terms of dramatic reductions in maternal mortality and protecting the newborn infant ... has been detailed in the biomedical literature," vaccinologist Peter Hotez told me by email. I asked Kennedy through his agency's public information team for comment on the CDC presentation, but received no reply. On June 9, Kennedy fired all 17 members of ACIP of the immunization advisory committee and replaced them with eight handpicked members, a cadre that includes "antivaxxers, the antivax-adjacent, and the unqualified," as veteran pseudoscience debunker David Gorski noted. The COVID vaccines have been a leading target of anti-vaccine activists, including Kennedy, since they were introduced in 2021. They've been blamed for a host of purported health harms, most of which have been found by researchers to be largely imaginary. The anti-vaccine camp maintains that the vaccines weren't adequately studied before rolling them out to the general public and haven't been sufficiently monitored for adverse effects since then. The CDC officials' presentation debunked almost all these claims. Indeed, Meyer said, the COVID-19 vaccines have been subjected to "the most extensive safety monitoring programe in US history." The CDC has investigated more than 65 possible adverse effects of the vaccine, Meyer said, including heart attacks, meningitis, spontaneous abortion, seizures and hospitalisation. Other than pain at the injection site, fainting and other transitory conditions common to most vaccines, it has found evidence for one condition — myocarditis, a heart inflammation seen especially in men aged 12 to 29. That appears to be a short-term condition, with 83% of patients recovering within 90 days of onset, and more than 90% fully recovered within a year. No deaths or heart transplants are known to have occurred, the CDC data show. No confirmed cases were seen in children younger than 5. The myocarditis rate among vaccine recipients aged between 6 months and 64 years appeared to spike in 2020-22, when it seemed to be related to the original vaccine and the original booster. After the booster was reformulated, the rate among those aged 12 to 39 fell to about one case per million doses in 2024-25 — half the rate found in the general population. Despite the relative rarity of myocarditis, the condition has underpinned a campaign by anti-vaccine activists to take the vaccines off the market. Among them is Joseph Ladapo, the Florida surgeon general, who in 2022 advised males aged 18-39 not to get the COVID vaccine. His advisory earned him a crisp upbraiding from the then-heads of the FDA and CDC, who informed him by letter that "the known and potential benefits of these vaccines clearly outweigh their known and potential risks.... Not only is there no evidence of increased risk of death following mRNA vaccines, but available data have shown quite the opposite: that being up to date on vaccinations saves lives compared to individuals who did not get vaccinated."
